This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Prevention and Treatment of COVID-19-Associated Mucormycosis
Current Treatment Options in Allergy Open Access 01 June 2023
-
Recent Advances in the Treatment of Mucormycosis
Current Infectious Disease Reports Open Access 10 August 2010
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Ullmann AJ, Lipton JH, Vesole DH, Chandrasekar P, Langston A, Tarantolo SR et al. Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease. N Engl J Med 2007; 356: 335–471.
Cornely OA, Maertens J, Winston DJ, Perfect J, Ullmann AJ, Walsh TJ et al. Posaconazole vs fluconazole or itraconazole prophylaxis in patients with neutropenia. N Engl J Med 2007; 356: 348–359.
Diekema D, Messer SA, Hollis RJ, Jones RN, Pfaller MA . Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole and amphotericin B against 448 recent clinical isolates of filamentous fungi. J Clin Microbiol 2003; 41: 3623–3626.
Dannaoui E, Meletiadis J, Mouton JW, Meis JF, Verweij PE . In vitro susceptibilities of zygomycetes to conventional and new antifungals. J Antimicrob Chemother 2003; 51: 45–52.
van Burik JAH, Hare RS, Solomon HF, Corrado ML, Kontoyiannis DP . Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases. Clin Infect Dis 2006; 42: e61–e65.
Greenberg RN, Mullane K, van Burik JAH, Raad I, Abzug MJ, Anstead G et al. Posaconazole as salvage therapy for zygomycosis. Antimicrob Agents Chemother 2006; 50: 126–133.
Marty FM, Cosimi L, Baden LR . Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants [letter]. N Engl J Med 2004; 350: 950–952.
Siwek GT, Dodgson KJ, de Magalhaes-Silverman M, Bartelt LA, Kilborn SB, Hoth PL et al. Invasive zygomycosis in hematopoietic stem cell transplant recipients receiving voriconazole prophylaxis. Clin Infect Dis 2004; 39: 584–587.
Trifilio SM, Bennett CL, Yarnold PR, McKoy JM, Parada J, Mehta J et al. Breakthrough zygomycosis after voriconazole administration among patients with hematologic malignancies who receive hematopoietic stem-cell transplants or intensive chemotherapy. Bone Marrow Transplant 2007; 39: 425–429.
Trifilio S, Singhal S, Williams S, Frankfurt O, Gordon L, Evens A et al. Breakthrough fungal infections after allogeneic hematopoietic stem cell transplantation in patients on prophylactic voriconazole. Bone Marrow Transplant 2007; 40: 451–456.
Dannaoui E, Meis J, Loebenberg D, Verweij PE . Activity of posaconazole in treatment of experimental disseminated zygomycosis. Antimicrob Agents Chemother 2003; 47: 3647–3650.
Acknowledgements
We thank the Centre National de Référence des Mycoses of Institut Pasteur, Paris, France for the help in identifying Rhyzopus and in determining the minimal inhibitory concentration.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Schlemmer, F., Lagrange-Xélot, M., Lacroix, C. et al. Breakthrough Rhizopus infection on posaconazole prophylaxis following allogeneic stem cell transplantation. Bone Marrow Transplant 42, 551–552 (2008). https://doi.org/10.1038/bmt.2008.199
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2008.199
This article is cited by
-
Prevention and Treatment of COVID-19-Associated Mucormycosis
Current Treatment Options in Allergy (2023)
-
Foiling fungal disease post hematopoietic cell transplant: review of prophylactic strategies
Bone Marrow Transplantation (2018)
-
Disseminated Scopulariopsis brevicaulis infection in an allogeneic stem cell recipient
Bone Marrow Transplantation (2011)
-
The Current Role of Posaconazole in Managing Zygomycosis
Current Fungal Infection Reports (2011)
-
Recent Advances in the Treatment of Mucormycosis
Current Infectious Disease Reports (2010)